Metoclopramide: Main structure for 5-HT3 and 5-HT4 receptor ligands;Metoclopramid: Leitstruktur fur 5-HT3- und 5-HT4-rezeptorliganden

Pharmazeutische Zeitung

Volumn 143, Issue 30, 1998, Pages 11-21

  Keller, Andreas ^a,b   Elz, Sigurd ^a,c   Schunack, Walter ^a,c  

^a Firma Serag Wiessner ^*

^b Firma Serag Wiessner   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 3 INDOLECARBOXYLIC ACID 2 (1 PIPERIDINYL)ETHYL ESTER; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (1 PIPERIDINYL)ETHYL ESTER; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 4 AMINO 5 CHLORO N [(HEXAHYDRO 1H PYRROLIZIN 1 YL)METHYL] 2 METHOXYBENZAMIDE; BEMESETRON; CILANSETRON; CISAPRIDE; DAU 6255; DOLASETRON MESILATE; DOMPERIDONE; DOPAMINE 2 RECEPTOR; GRANISETRON; ITASETRON; METOCLOPRAMIDE; MOSAPRIDE CITRATE; ONDANSETRON; PROCAINAMIDE; RAMOSETRON; RS 17017; RS 56532; RS 57639; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SULPIRIDE; TEGASEROD; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZACOPRIDE; ZATOSETRON;

BILE DUCT DYSKINESIA; DRUG DEVELOPMENT; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL MOTILITY; HUMAN; NAUSEA; PYLORUS STENOSIS; REFLUX ESOPHAGITIS; REVIEW; VOMITING;

EID: 0032560727     PISSN: 00317136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Neue Arzneimittel, Dtsch. Apoth. Ztg. 105 Beilage (1965) 179.
2. Justin-Besançon, L., et al., C. R. Acad Sci. 158 (1964) 4384 - 4836.
3. Malrnejac, J , Laville, C., Path. Biol. 12 (1964) 1074 - 1078
4. Robinson, O P W., Postgrad. Med. J. 49, Suppl. 4 (1973) 9 - 12.
5. McNeilly, A. S , et al., Br. Med. J. 2 (1974) 729.
6. Jacoby, H. I , Brodie, D. A., Gastroenterology 52 (1967) 676.
7. Andrews, P. L A., et al., Trends Pharmacol. Sci. 9 (1988) 334 - 341.
8. Pinder, R M , et al , Drugs 12 (1976) 81 - 131.
9. Justin-Besancon, L., Laville, C., C. R Acad. Sci. 158 (1964) 723 - 727
10. Briejer, M. R., et al., Pharmacol. Rev 47 (1995) 631 - 651.
11. Keller, A . Dissertation, Berlin 1996.
12. Kebabian, J. W., Calne, D. B., Nature (London) 277 (1979) 93 - 96.
13. th ed., 1997, S. 32.
14. Sokoloff, P , Schwartz, J.-C , Trends Pharmacol. Sci. 16 (1995) 270 - 275
15. Cunningham Owens, D. G , Drugs 51 (1996) 895 - 930
16. Forth, W , Rummel, W., In: Allgemeine und spezielle Pharmakologie und Toxikologie, Hrsg. Forth, W . et al., BI-Wissenschaftsverlag. Mannheim, 6. Aufl 1992, S. 482.
17. Reyntjens, A. J., et al., Arzneim.-Forsch. 28 (1978) 1194 - 1196.
18. Vialli, M., Ersparmer, V., Z. Zellforsch. Mikroskop. Anat. 19 (1933) 743.
19. Hoyer, D., et al., Pharmacol. Rev. 45 (1994) 157 - 203.
20. Fischer, W., Pharm. Uns. Zeit 20 (1991) 21 - 31.
21. Gaddum, J H., Picarelli, Z. P., Br. J. Pharmacol Chemother. 12 (1957) 323 - 328.
22. Bradley, P. B., et al , Neuropharmacology 25 (1986) 563 - 576.
23. Peroutka, S. J., Snyder, S. H., Mol. Pharmacol. 16 (1979) 687-699.
24. Hoyer, D., Trends Pharmacol. Sci. 9 (1988) 89 - 94.
25. Gerald, D., et al., EMBO J. 14 (1995) 2806 - 2815.
26. Gill, C. H., et al., Br. J. Pharmacol. 114 (1995) 1211 - 1221.
27. Butler, A., et al., Br. J. Pharmacol. 101 (1990) 591 - 598
28. Hoyer, D., Neuropharmacology 3 (1990) 371 - 383.
29. Yakel, J L., Jackson, M. B., Neuron 1 (1988) 615 - 621.
30. Kilpatrick, G J., et al., Nature (London) 330 (1987) 746 - 748.
31. Hoyer, D., Neijt, H. C , Mol. Pharmacol. 33 (1988) 303 - 309.
32. Kilbinger, H., Pfeuffer-Friederich, I., Br. J. Pharmacol. 85 (1985) 529 - 539
33. Kilpatrick, G. J , et al , Eur. J. Pharmacol. 182 (1990) 193 - 197.
34. Eiden, F., Lentzen, H , Pharm. Uns. Zeit 25 (1996) 28 - 38.
35. Ponchant, M., et al., J. Labelled Compd. Radiopharm. 29 (1991) 1147 - 1155.
36. Nagel, A., et al., J. Med. Chem. 33 (1990) 13 - 16.
37. Costall, B., Naylor, R. J., Handb. Exp. Pharmacol. 129 (1997) 409 - 438.
38. Ohta, M., Miyata, K., Drugs Fut. 17 (1992) 28 - 29.
39. Dumuis, A., et al., Mol. Pharmacol. 34 (1988) 880 - 887.
40. Shenker, A., et al., Eur. J. Pharmacol. 109 (1985) 427 - 429.
41. Dumuis, A., Eur. J. Pharmacol. 162 (1988) 381 - 384.
42. Kilbinger, H., Wolf, D., Naunyn-Schmiedeberg's Arch. Pharmacol. 345 (1992) 270 - 275
43. Baxter, G. S., Naunyn-Schmiedeberg's Arch. Pharmacol. 343 (1991) 439 - 446.
44. Kaumann, A. J., Naunyn-Schmiedeberg's Arch. Pharmacol. 342 (1990) 619 - 622.
45. Kaumann, A. J., et al., Br. J. Pharmacol. 100 (1990) 879 - 885.
46. Tonini, M., et al., Br. J. Pharmacol. 113 (1994) 1 - 2.
47. Idres, S., et al., Mol. Brain Res. 10 (1991) 251 - 258.
48. Lefebvre, H., et al., Neuroscience 47 (1992) 999 - 1007.
49. Corsi, M., et al., Br. J. Pharmacol 104 (1991) 719 - 725.
50. Bockaert, J., et al., CNS Drugs 1 (1994) 6 - 15.
51. Bonhomme, N., et al., Neuropharmacology 34 (1995) 269 - 279.
52. Gerald, C., et al., Synaptic Pharmaceutical Corp., WO94/14,957 (1994).
53. Leung, E , et al., Naunyn-Schmiedeberg's Arch Pharmacol. 354 (1996) 145 - 156.
54. Kaumann, A. J., Trends Pharmacol Sci. 15 (1994) 451 - 455
55. Elz, S., Keller, A., Arch. Pharm (Weinheim) 326 (1993) 671; Elz, S , Keller, A., Arch. Pharm. Pharm. Med. Chem. 328 (1995) 585-594
56. Elz, S., Keller, A., Arch. Pharm (Weinheim) 326 (1993) 671; Elz, S , Keller, A., Arch. Pharm. Pharm. Med. Chem. 328 (1995) 585-594
57. Langlois, M., et al., XIIIth International Symposium on Medicinical Chemistry. Paris, Sept. 19 - 23, Poster P105 (1994); Langlois, M., et al., Bioorg. Med Chem Lett. 4 (1994) 1433 - 1436.
58. Langlois, M., et al., XIIIth International Symposium on Medicinical Chemistry. Paris, Sept. 19 - 23, Poster P105 (1994); Langlois, M., et al., Bioorg. Med Chem Lett. 4 (1994) 1433 - 1436.
59. King, F. D., et al., SmithKline Beecham Pharmaceuticals, WO93/03725 (1992).
60. Clark, R. D., et al., Bioorg. Med. Chem. Lett. 4 (1994) 2477 - 2480.
61. Bockaert, J., et al., Handb. Exp. Pharmacol. 129 (1997) 439 - 474.
62. Buchheit, K.-H., et al., Naunyn-Schmiedeberg's Arch. Pharmacol. 345 (1992) 387 - 393
63. Sokoloff, P., et al., Eur. J. Pharmacol. Mol. Pharmacol. Sect. 225 (1992) 331 - 337.
64. Eglen, R. M., et al , Br. J. Pharmacol. 101 (1990) 513 - 520.
65. Flynn, D. L., et al., J. Med. Chem. 35 (1992) 1489 - 1491.